STAT3 and ovarian cancer: Given the very promising and specific SKOV3 viability reduction that we observed for anti-STAT3 mcDNA in the MTS assay, we proceeded to evaluate the underlying effects of our compound on apoptosis and necrosis in these representative ovarian cancer cells.